Proactive Reduction of Outpatient Malpractice: Increasing Safety, Efficiency, and Satisfaction
PROMISES
Medical Malpractice and Patient Safety Proposal
2 other identifiers
interventional
213
1 country
2
Brief Summary
The purpose of the Proactive Reduction of Outpatient Malpractice: Increasing Safety, Efficiency, and Satisfaction (PROMISES) project is to assemble a high-level Massachusetts consortium to test the impact of powerful quality improvement techniques to accomplish innovations and improvements in high risk ambulatory malpractice areas. We will target problem-prone processes in 3 areas of identified risk: 1) medication management, 2) test ordering and results management 3) follow-up and referral management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2010
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
December 3, 2012
CompletedFirst Posted
Study publicly available on registry
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedJanuary 1, 2013
December 1, 2012
2.9 years
December 3, 2012
December 24, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Staff and patient survey response distribution related to lab test result tracking, referral follow-up, medication management, and communication with patients and among practice staff
Evidence of change in the distribution of staff and patient survey responses related to lab test result tracking, referral follow-up, medication management, and communication with patients and among practice staff
Baseline and 15 months
Secondary Outcomes (3)
Number of abnormal lab or test results with improper clinical follow-up
Baseline and 15 Months
Number of specialist referral recommendations with improper clinical follow-up
Baseline and 15 Months
Number of contraindicated medication prescriptions
Baseline and 15 Months
Study Arms (2)
Improvement Sessions
EXPERIMENTALWe will implement a context-sensitive collaborative improvement model that will emphasize training and in-office coaching by quality improvement, efficiency and safety experts, as well as shared learning methods to develop, test and implement changes in the following four key risk areas: medication management; test and lab results management; follow-up and referral management; and communication - within and between practices as well as with patients.
Control
NO INTERVENTIONControl practices will not receive training or in-office coaching.
Interventions
Participating practices will be coached to perform rapid, small-scale tests of change and to iteratively improve performance of problem-prone care systems, as well as to imbed simple measurement in routine daily work streams to guide improvement efforts. The sixteen intervention practices will serve as realistic research laboratories to help advance malpractice risk prevention and patient safety in specific areas by refining tools and strategies for smaller practices.
Eligibility Criteria
You may qualify if:
- Primary Subjects: staff members of small to medium-sized primary care (internal medicine or family medicine) practices in Massachusetts with adult, English-speaking patients.
- Secondary Subjects: English-speaking adults who receive care at an enrolled intervention or control office practice.
You may not qualify if:
- Non-English-speaking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Massachusetts Department of Healthlead
- Brigham and Women's Hospitalcollaborator
- Massachusetts Coalition for the Prevention of Medical Errorscollaborator
- Institute for Healthcare Improvementcollaborator
- Massachusetts Medical Societycollaborator
- Healthcare for Allcollaborator
- Cricocollaborator
- Coveryscollaborator
- Agency for Healthcare Research and Quality (AHRQ)collaborator
Study Sites (2)
Massachusetts Department of Public Health
Boston, Massachusetts, 02111, United States
Brigham and Women's Hospital
Boston, Massachusetts, 02120, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Madeleine Biondolillo, MD
Massachusetts Department of Health
- STUDY CHAIR
Gordon Schiff, MD
Brigham and Women's Hospital
- STUDY DIRECTOR
Nicholas Leydon, MPH
Massachusetts Department of Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of the Bureau of Health Care Safety and Quality
Study Record Dates
First Submitted
December 3, 2012
First Posted
January 1, 2013
Study Start
July 1, 2010
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
January 1, 2013
Record last verified: 2012-12